Clinical Trials in Immunotherapy

Precision Medicine World Conference (PMWC) 2017 Podium Presentation

Undeniably, cancer immunotherapy is one of the most promising areas in cancer research. New clinical trial approaches are under way to advance immune therapies for cancer. In this presentation, industry and medical representatives including Patrice Hugo, PhD, Chief Scientific Officer, Q2 Solutions, discuss their novel and innovative immunotherapy programs which aim to expedite treatment of cancer. Download this presentation to learn more about cancer immunotherapy trials and the future of cancer treatment. 

View full presentation here.


Patrice Hugo, CSO, Q2 Solutions
Jonathan Cheng, Section Head/PDT Lead SCCHN, GCD Oncology, Merck
Samir Khleif, Director of GRU Cancer Center, Augusta University
Jim Novotny, Group Director, Pharmacodiagnostics, Bristol-Myers Squib